26 test positive for dengue in Jammu region

Jammu: At least 26 people have tested positive for dengue in five districts of Jammu region this year, a health official said Sunday. The maximum 11 cases were reported from Kathua district followed by seven in Samba, six in Jammu and one each in Kishtwar and Udhampur districts, the official said.

He said the people who tested positive for the vector-borne disease included 10 women and five boys.

A total of 460 samples were taken for screening since January, the official said, adding, 442 test reports were received by Saturday evening, of which 416 were found negative.

Eighteen test reports were awaited.

He said a majority of the cases tested positive for dengue last month.

The first dengue case was reported in January, one in July and two in August, while two cases were found positive this month, he said. Twenty cases were reported last month.

Among those tested positive, the official said three residents of Jammu were outside the state.

The official said there was no need to panic as all necessary measures have been taken to keep the situation under control.

The dengue cases usually go up after the monsoon season as the main trigger for the disease is stagnant water, he said, and advised people not to allow water to stagnate around residential structures.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid